Dr. Ruchi Singh

  • Name Dr. Ruchi Singh
  • DesignationHOD & Senior Consultant Radiation Oncology
  • SpecialistCancer Treatment
Hospital Designation
HOD & Senior Consultant- Radiation Oncology
Brief Profile

13 years+ experience of working in Premium Cancer Institutes of India with Teletherapy units (3DCRT, IMRT, IGRT, SBRT, SRT, TBI & Gating), Brachytherapy unit, Treatment Planning System (MONACO, XIO, ECLIPSE, PLATO, ONCENTRA ), Chemotherapy drugs, Radioprotective agents and Monoclonal antibodies for various Solid tumors.

Experience
  • Senior Consultant Radiation Oncology, I0CI, Fortis Hospital, Noida(Oct, 2020 to till March 2024) 
  • Associate Consultant, Radiation Oncology, Max Hospital Patparganj (Dec,2017-Oct,2020). 
  • Senior Resident, Lok Nayak Hospital, MAMC, New Delhi (Dec 2014 to July 2017).
  • Senior Resident, Medanta The Medicity, Gurgaon (March 2014 to Dec 2014).
  • Senior Resident, Safdarjung Hospital  VMMC, New Delhi (Oct 2013 to March 2014).
Education & Fellowship
  • M.B.B.S, Gujarat University/B. J. Medical College, Ahmedabad India.
  • MD Radiotherapy, Gujarat University/ Gujarat Cancer Research Institute (GCRI), Ahmedabad, India.
Achievements
  • 3rd Position In 10th UP Board 2000 
  • 17th Position in 12th UP-Board 2002
  • IP Gujral Best Paper Award in 2012
  • MD, Radiotherapy 1st Position, Gujarat University, 2013 
  • Organized Various Conferences and CME
  • Associated with various NGO and cancer awareness programs 
Speciality Interest
  • Gynecological Cancers (Cervix, Uterus etc.)
  • Breast Cancers (DIBH)
  • Head & Neck Cancers (Oral cavity, Larynx, Hypopharynx and Nasopharynx etc.) 
  • Urological Cancers (Prostate, Urinary Bladder etc.)
  • Neuro-Oncology
  • Palliative and Preventive Oncology
  • Brachytherapy
  • SBRT, SRS, SRT, DIBH, IGRT, IMRT, Gating, TBI, TSET
Professional Memberships
  • Delhi Medical Council 
  • Gujarat Medical Council 
  • UP Medical Council
  • MCI
  • Life Member of Association of Radiation Oncologists of India. 
  • Life member –Oncology forum
Presentation:
  • Analysis Of Levels Of Insulin Like Growth Factor-I and Insulin Like Growth Factor-I I In Patients Of Carcinoma Cervix, MP Gujarat Chapter Conference, 2011, Indore. (Awarded the ‘BEST PAPER AWARD’).
Publication:
  • Need, benefit and future issues of the young radiation oncologist attending the first (1st) Masterclass on head and neck cancer radiotherapy: from 2D to Cyberknife.  Asian Journal of Radiation Oncology 12/2013; 1(2):60-63.
  • Chapter-17 Carcinoma of Anal Canal. Chapter · January 2016, DOI: 10.5005/jp/books/12793_18. In book: Principles and Management of Cancer, pp.204-209. Basu T, Singh  R, Kataria.
  • Radiotherapy for Pediatric Solid Tumours, Section 11, Paediatric Surgery  Update,2015.
  •  Kharbanda Y, Singh R, Mir T, Tanwar YS. Extensive Re-ossification and Reformation of the Proximal Femur After External Beam Radiotherapy in Metastatic Carcinoma Breast. Indian J Surg Oncol. 2018 Sep;9(3):394-397.doi:10.1007/s13193-018-0739-5. https://pubmed.ncbi.nlm.nih.gov/30288005/.
  • Tanwar YS, Kharbanda Y, Rastogi R, Singh R. Desmoplastic Fibroma of Bone: a Case Series and Review of Literature. Indian J Surg Oncol. 2018;9(4):585-591.doi:10.1007/s13193-018-0767-1.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265178/.
  • Saxena T, Singh R, Walia M, Guglani B, Ambastha R. Aggressive Angiomyxoma: A Case Report and Review of Literature. Ann Clin Case Rep. 2021; 6: 1916. Aggressive Angiomyxoma: A Case Report and Review of Literature (anncaserep.com).
Poster:
  • Comparative Study Of IMRT VS Conventional Radiotherapy With Amifostine For Preservation Of Parotid Function In Patients With Head And Neck Cancer , IFHNOS 2012 & 12 TH National Conference Of FHNO , Ahmedabad.
OPD Timing:
  • Mon , Tuesday, Thursday & Saturday : 10:00 to 4:00 pm
  • Wed & Friday : 2:00 pm to 4:00 pm

Know More About Department